ZA200408245B - Dry powder compositions - Google Patents

Dry powder compositions

Info

Publication number
ZA200408245B
ZA200408245B ZA200408245A ZA200408245A ZA200408245B ZA 200408245 B ZA200408245 B ZA 200408245B ZA 200408245 A ZA200408245 A ZA 200408245A ZA 200408245 A ZA200408245 A ZA 200408245A ZA 200408245 B ZA200408245 B ZA 200408245B
Authority
ZA
South Africa
Prior art keywords
dry powder
powder compositions
compositions
dry
powder
Prior art date
Application number
ZA200408245A
Other languages
English (en)
Inventor
Roche Trevor Charles
Bulsara Pallav Arvind
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ZA200408245B publication Critical patent/ZA200408245B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA200408245A 2002-04-13 2004-10-12 Dry powder compositions ZA200408245B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0208608.0A GB0208608D0 (en) 2002-04-13 2002-04-13 Composition

Publications (1)

Publication Number Publication Date
ZA200408245B true ZA200408245B (en) 2007-03-28

Family

ID=9934855

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200408245A ZA200408245B (en) 2002-04-13 2004-10-12 Dry powder compositions

Country Status (19)

Country Link
US (1) US20050244340A1 (enExample)
EP (1) EP1494644A1 (enExample)
JP (1) JP2005530733A (enExample)
KR (1) KR20040099436A (enExample)
CN (1) CN1658839A (enExample)
AR (1) AR039409A1 (enExample)
AU (1) AU2003217073A1 (enExample)
BR (1) BR0309114A (enExample)
CA (1) CA2481467A1 (enExample)
GB (1) GB0208608D0 (enExample)
IL (1) IL164420A0 (enExample)
IS (1) IS7500A (enExample)
MX (1) MXPA04010080A (enExample)
NO (1) NO20044497L (enExample)
PL (1) PL373294A1 (enExample)
RU (1) RU2004130439A (enExample)
TW (1) TW200404008A (enExample)
WO (1) WO2003088943A1 (enExample)
ZA (1) ZA200408245B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005507881A (ja) 2001-09-17 2005-03-24 グラクソ　グループ　リミテッド 乾燥粉末医薬製剤
SE526509C2 (sv) * 2003-06-19 2005-09-27 Microdrug Ag Kombinerade doser av formoterol och budesonid separerade på en gemensam dosbädd
JP2009513529A (ja) * 2003-07-11 2009-04-02 グラクソ グループ リミテッド ステアリン酸マグネシウムを含む医薬製剤
EP1643974A1 (en) * 2003-07-11 2006-04-12 Glaxo Group Limited Inhalable pharmaceutical formulations comprising a sugar ester
AR049384A1 (es) 2004-05-24 2006-07-26 Glaxo Group Ltd Derivados de purina
WO2006066907A1 (en) * 2004-12-21 2006-06-29 Glaxo Group Limited Pharmaceutical formulations
NZ556709A (en) * 2005-02-10 2009-09-25 Glaxo Group Ltd Process for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
JP2009545579A (ja) 2006-08-01 2009-12-24 グラクソ グループ リミテッド ピラゾロ［３，４−ｂ］ピリジン化合物、及びｐｄｅ４阻害薬としてのその使用
GB0921075D0 (en) * 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
CN105324107A (zh) * 2013-04-29 2016-02-10 赛诺菲股份有限公司 可吸入药用组合物和含有该药用组合物的吸入器装置
AU2015296024A1 (en) * 2014-08-01 2017-03-23 Luxena Pharmaceuticals, Inc. Palonosetron formulations and uses thereof
PT109030B (pt) * 2015-12-15 2019-09-25 Hovione Farmaciência, S.A. Preparação de partículas inaláveis de zafirlucaste
CN110237373B (zh) * 2018-03-08 2023-06-02 润生药业有限公司 一种生产用于联合用药的药物载体的装置及方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR8007911A (pt) * 1979-12-06 1981-06-16 Glaxo Group Ltd Inalador aperfeicoado
SE448277B (sv) * 1985-04-12 1987-02-09 Draco Ab Indikeringsanordning vid en doseringsanordning for lekemedel
FI88112C (fi) * 1985-07-30 1993-04-13 Glaxo Group Ltd Anordning foer administrering av laekemedel till patienter
GB9004781D0 (en) * 1990-03-02 1990-04-25 Glaxo Group Ltd Device
JPH04220268A (ja) * 1990-12-19 1992-08-11 Olympus Optical Co Ltd バルーンカテーテル
ZA9711732B (en) * 1996-12-31 1998-12-28 Quadrant Holdings Cambridge Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery
DE69809746T2 (de) * 1997-07-03 2004-09-30 Elan Drug Delivery Ltd., Ruddington Modifiziere glykoside, modifizierte glyckoside enthaltende zusammensetzungen und verfahren zu ihrer herstellung
US6352722B1 (en) * 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
HU226164B1 (en) * 1998-11-13 2008-05-28 Jagotec Ag Use of magnesium stearate in dry powder compositions suitable for inhalation and compositions suitable for inhalation
GB9916316D0 (en) * 1999-07-12 1999-09-15 Quadrant Holdings Cambridge Dry powder compositions
GB0015981D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
GB0020616D0 (en) * 2000-08-21 2000-10-11 Quadrant Holdings Cambridge Particulates
WO2002043750A2 (en) * 2000-12-01 2002-06-06 Battelle Memorial Institute Method for the stabilizing of biomolecules (e.g. insulin) in liquid formulations
GB0103630D0 (en) * 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
CN1658839A (zh) 2005-08-24
US20050244340A1 (en) 2005-11-03
RU2004130439A (ru) 2005-06-10
KR20040099436A (ko) 2004-11-26
IL164420A0 (en) 2005-12-18
IS7500A (is) 2004-10-11
GB0208608D0 (en) 2002-05-22
CA2481467A1 (en) 2003-10-30
WO2003088943A1 (en) 2003-10-30
AR039409A1 (es) 2005-02-16
AU2003217073A1 (en) 2003-11-03
EP1494644A1 (en) 2005-01-12
BR0309114A (pt) 2005-02-01
NO20044497L (no) 2004-11-15
TW200404008A (en) 2004-03-16
JP2005530733A (ja) 2005-10-13
PL373294A1 (en) 2005-08-22
MXPA04010080A (es) 2004-12-13

Similar Documents

Publication Publication Date Title
GB0326632D0 (en) Dry powder formulations
GB0212062D0 (en) Jetable compositions
IL165372A0 (en) Immunodenic compositions
EP1487524A4 (en) INHALER FOR DRY POWDER
IL162858A0 (en) Dry powder inhaler
GB0224415D0 (en) Compositions
IL164421A0 (en) Dry powder inhalant composition
AU2003218121A8 (en) Lotion compositions
GB0214805D0 (en) Cosmetic compositions
ZA200408245B (en) Dry powder compositions
GB0221894D0 (en) Compositions
GB0201163D0 (en) Antiperspirant compositions
AU2003269904A8 (en) Antigen-polymer compositions
GB0203395D0 (en) Compositions
GB0203396D0 (en) Compositions
GB2372518B (en) Powder composition
GB0217366D0 (en) Compositions
AU2003255721A8 (en) Perfume compositions
GB2394114B (en) Compositions
AU2003216382A8 (en) Idothyronine compositions
AU2003218497A8 (en) Factorviia compositions
HK1074384A (en) Dry powder compositions
GB0217840D0 (en) Cosmetic compositions
GB0226159D0 (en) Compositions
GB0203356D0 (en) Compounds compositions and uses